|Articles|June 15, 2004
Phakic IOL preserves endothelial cell count outcome measure
Study shows cell loss equal to natural aging, allowing IOL to be implanted in young patients
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
AAO 2025: Kenneth C. Fan, MD, sees vision gains with MCO-010 in Stargardt disease
3
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
4
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
5